Rubia, Mary Ann .
HRN: 12-54-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/25/2024
CEFUROXIME 1.5GM (VIAL)
11/26/2024
11/26/2024
IV
1.5 Gra
PTOR
Prophylaxis For Repeat CS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes